How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

The US AI research company Anthropic has become known for building powerful AI models while simultaneously warning about their dangers. “We are not there yet, and recursive self-improvement is not ...

News headlines Recursion Pharmaceuticals reported mixed Q2 results, with revenue declining significantly and net loss improving. Despite progress in clinical trials and partnerships, analysts express ...

Food sources high in vitamin C include citrus fruits, certain types of cherries and peppers, and fresh parsley. Vitamin C is essential for connective tissue and bone health, immune system function, ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...